Rhumbline Advisers »

Relmada Therapeutics shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.9k 1.2k 4.14
2023-09-30 $3.5k 1.2k 3.00
2023-06-30 $8.5k 3.4k 2.46
2023-03-31 $85k 38k 2.26
2022-12-31 $128k 37k 3.50
2022-09-30 $1.3M 36k 37.01
2022-06-30 $635k 33k 18.99
2022-03-31 $582k 22k 27.00
2021-12-31 $351k 16k 22.52
2021-09-30 $415k 16k 26.22
2021-06-30 $485k 15k 32.01
2021-03-31 $577k 16k 35.20
2020-12-31 $549k 17k 32.05
2020-09-30 $602k 16k 37.63
2020-06-30 $798k 18k 44.72